Richard D. Carr

4.7k total citations · 1 hit paper
66 papers, 3.7k citations indexed

About

Richard D. Carr is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Richard D. Carr has authored 66 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in Richard D. Carr's work include Diabetes Treatment and Management (35 papers), Pancreatic function and diabetes (21 papers) and Neuropeptides and Animal Physiology (14 papers). Richard D. Carr is often cited by papers focused on Diabetes Treatment and Management (35 papers), Pancreatic function and diabetes (21 papers) and Neuropeptides and Animal Physiology (14 papers). Richard D. Carr collaborates with scholars based in Denmark, United Kingdom and United States. Richard D. Carr's co-authors include Carolyn F. Deacon, Derek M. Yellon, Mihaela Mocanu, Christian L. Brand, Amal Bose, Bo Åhrén, Bidda Rolin, Jens J. Holst, Marianne O. Larsen and Michael Wilken and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Richard D. Carr

66 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury

2005 504 citations Amal Bose, Mihaela Mocanu et al. Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard D. Carr Denmark	30	2.3k	1.4k	1.2k	499	426	66	3.7k
Takahisa Hirose Japan	34	2.1k 0.9×	1.2k 0.9×	1.3k 1.1×	845 1.7×	270 0.6×	166	4.8k
Neeraj K. Saxena United States	41	1.3k 0.6×	977 0.7×	2.1k 1.7×	787 1.6×	301 0.7×	98	6.1k
Per‐Anders Jansson Sweden	34	1.7k 0.7×	911 0.7×	1.3k 1.1×	1.6k 3.3×	437 1.0×	71	5.0k
Luigi Gnudi United Kingdom	41	1.5k 0.6×	884 0.6×	2.4k 1.9×	1.3k 2.6×	193 0.5×	121	5.9k
Baptist Gallwitz Germany	39	4.2k 1.8×	2.2k 1.6×	1.9k 1.6×	677 1.4×	748 1.8×	129	5.7k
Ole Schmitz Denmark	29	2.3k 1.0×	1.5k 1.1×	1.5k 1.2×	751 1.5×	148 0.3×	57	3.6k
Yukiko Onishi Japan	33	1.6k 0.7×	692 0.5×	1.6k 1.3×	890 1.8×	111 0.3×	76	3.7k
Shigeaki Baba Japan	35	1.1k 0.5×	1.5k 1.1×	1.2k 1.0×	487 1.0×	615 1.4×	239	3.6k
Tatsuo Shimosawa Japan	32	830 0.4×	559 0.4×	1.5k 1.2×	635 1.3×	708 1.7×	151	3.9k
Erik Frandsen Denmark	30	1.0k 0.4×	582 0.4×	619 0.5×	414 0.8×	354 0.8×	69	2.5k

Countries citing papers authored by Richard D. Carr

Since Specialization

Citations

This map shows the geographic impact of Richard D. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Carr more than expected).

Fields of papers citing papers by Richard D. Carr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Carr. The network helps show where Richard D. Carr may publish in the future.

Co-authorship network of co-authors of Richard D. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Carr. A scholar is included among the top collaborators of Richard D. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Carr. Richard D. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rogdaki, Maria, Robert A. McCutcheon, Enrico D’Ambrosio, et al.. (2024). Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis. The Lancet Child & Adolescent Health. 8(7). 510–521. 11 indexed citations

Albrechtsen, Nicolai J. Wewer, Bolette Hartmann, Richard D. Carr, et al.. (2019). 1002-P: Sacubitril/Valsartan Increases Postprandial Glucagon-Like Peptide-1 Concentrations and Has Synergistic Effects when Combined with Sitagliptin. Diabetes. 68(Supplement_1). 1 indexed citations

Berger, Joel P., Ranabir SinhaRoy, Alessandro Pocai, et al.. (2017). A comparative study of the binding properties, dipeptidyl peptidase‐4 (DPP‐4) inhibitory activity and glucose‐lowering efficacy of the DPP‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice. Endocrinology Diabetes & Metabolism. 1(1). e00002–e00002. 67 indexed citations

Carr, Richard D., et al.. (2016). Nontuberculous mycobacterial adenitis outside of the head and neck region in children: A case report and systematic review of the literature. International Journal of Mycobacteriology. 5(3). 351–353. 7 indexed citations

Eldredge, Jonathan D., et al.. (2012). Library and Informatics Skills Competencies Statements from Major Health Professional Associations. Medical Reference Services Quarterly. 31(1). 34–44. 8 indexed citations

Åhrén, Bo, Richard D. Carr, & Carolyn F. Deacon. (2010). Incretin Hormone Secretion Over the Day. Vitamins and hormones. 84. 203–220. 40 indexed citations

Simonsen, Lene, et al.. (2009). Inhibition of Neutral Endopeptidase 24.11 does not Potentiate the Improvement in Glycemic Control Obtained with Dipeptidyl Peptidase-4 Inhibition in Diabetic Goto–Kakizaki Rats. Hormone and Metabolic Research. 41(11). 851–853. 8 indexed citations

Carr, Richard D. & Heimar F. Marin. (2008). Nursing Care Systems: Enhancing Care Processes in Practice and Management. Yearbook of Medical Informatics. 17(1). 25–28. 1 indexed citations

Gram, Dorte X., Bo Åhrén, I. Nagy, et al.. (2007). Capsaicin‐sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. European Journal of Neuroscience. 25(1). 213–223. 116 indexed citations

10.

Eldredge, Jonathan D. & Richard D. Carr. (2007). Public health informatics training in New Mexico*. Journal of the Medical Library Association JMLA. 95(3). 343–346. 7 indexed citations

11.

Bose, Amal, Mihaela Mocanu, Richard D. Carr, & Derek M. Yellon. (2007). Myocardial Ischaemia-reperfusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In Vitro Rat Heart and may Involve the p70s6K Pathway. Cardiovascular Drugs and Therapy. 21(4). 253–256. 107 indexed citations

12.

Deacon, Carolyn F., Richard D. Carr, Thure Krarup, et al.. (2006). Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. European Journal of Endocrinology. 155(3). 485–493. 155 indexed citations

13.

Winzell, Maria Sörhede, et al.. (2006). Glucose-Induced Incretin Hormone Release and Inactivation Are Differently Modulated by Oral Fat and Protein in Mice. Endocrinology. 147(7). 3173–3180. 101 indexed citations

14.

Plamboeck, Astrid, Jens J. Holst, Richard D. Carr, & Carolyn F. Deacon. (2005). Neutral Endopeptidase 24.11 and Dipeptidyl Peptidase IV are Both Involved in Regulating the Metabolic Stability of Glucagon-like Peptide-1 in vivo. Kluwer Academic Publishers eBooks. 524. 303–312. 13 indexed citations

15.

Davies, Gareth, M. Julie Thornton, Yi‐Ju Chen, et al.. (2005). Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles. Journal of Investigative Dermatology. 124(4). 686–694. 35 indexed citations

16.

Plamboeck, Astrid, Jens J. Holst, Richard D. Carr, & Carolyn F. Deacon. (2005). Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig. Diabetologia. 48(9). 1882–1890. 142 indexed citations

17.

Larsen, Marianne O., Bidda Rolin, Ulla Ribel, et al.. (2003). Valine Pyrrolidide Preserves Intact Glucose‐Dependent Insulinotropic Peptide and Improves Abnormal Glucose Tolerance in Minipigs With Reduced β‐Cell Mass. Journal of Diabetes Research. 4(2). 93–105. 14 indexed citations

18.

Larsen, Mette Bach, et al.. (2002). The conscious Göttingen minipig as a model for studying rapid pulsatile insulin secretion in vivo. Diabetologia. 45(10). 1389–1396. 14 indexed citations

19.

Millar, J. Cameron, W. S. WILSON, Richard D. Carr, & Robert G. Humphries. (1995). Drug Effects on Intraocular Pressure and Vascular Flow in the Bovine Perfused Eye Using Radiolabelled Microspheres. Journal of Ocular Pharmacology and Therapeutics. 11(1). 11–23. 11 indexed citations

20.

Carr, Richard D., et al.. (1990). Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin‐converting enzyme. British Journal of Pharmacology. 100(1). 83–89. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact